Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death

B Brandt1, E F Abou-Eladab, M Tiedge

  • 1Medical Faculty, Department of Medical Biochemistry and Molecular Biology, University of Rostock, Rostock, Germany.

Cell Death & Disease
|March 3, 2011
PubMed

Insights

Galectin-1 (gal-1) activates the JNK/c-Jun/AP-1 pathway, leading to T-cell apoptosis. This study elucidates gal-1

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Galectin-1 (gal-1) is an endogenous lectin involved in T-cell apoptosis.
  • T-cell death can be mediated by death receptor and mitochondrial pathways.

Purpose of the Study:

  • To investigate the molecular mechanisms by which gal-1 induces T-cell death.
  • To identify the role of the JNK/c-Jun/AP-1 pathway in gal-1-mediated apoptosis.

Main Methods:

  • Jurkat T cells were treated with gal-1.
  • Inhibition of JNK, PKCδ, and PKCθ pathways using specific inhibitors.
  • Analysis of c-Jun phosphorylation, AP-1 activity, and Bcl-2 family protein expression.
  • Use of CD3-deficient Jurkat cells to assess T-cell receptor dependence.

Main Results:

  • Gal-1 activates c-Jun N-terminal kinase (JNK) via MKK4 and MKK7.
  • Ceramide and PKCδ/PKCθ phosphorylation mediate gal-1-induced JNK activation.
  • JNK activation leads to c-Jun phosphorylation and AP-1 DNA-binding activity.
  • Inhibition of JNK or AP-1 reduces gal-1-induced DNA fragmentation.
  • Gal-1 induces a proapoptotic signaling pattern, including altered Bcl-2 family protein expression.

Conclusions:

  • The JNK/c-Jun/AP-1 pathway is crucial for gal-1-induced T-cell apoptosis.
  • Gal-1-mediated T-cell death is partly dependent on T-cell receptor signaling.
  • These findings offer insights into T-cell death regulation by gal-1.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...